NovaShunt Raises $25M in Series B
Swiss medical device start-up NovaShunt AG has raised roughly $25 million in Series B financing. BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund co-led the round, which included participation from existing shareholders NeoMed and VI Partners. NovaShunt is developing an implantable pump system that continually removes excess abdominal fluid in patients suffering from liver cirrhosis, certain cancers and congestive heart failure.
9 March 2011•4 mins read
